191 |
ENCAPSULATION OF FOLIC ACID IN MESOPOROUS SILICA SUPPORTS: A NUTRITIONAL AND TECHNOLOGICAL APPROACHPérez Esteve, Edgar 09 December 2015 (has links)
Tesis por compendio / [EN] The present PhD thesis, entitled "Encapsulation of folic acid in silica porous supports: a nutritional and technological approach", focuses on the development of new smart systems for the controlled delivery of folic acid for nutritional applications.
The first part of the thesis shows folic acid encapsulation in polyamines-functionalized silica porous matrices from a nutritional approach. The first part evaluates not only the influence of the loading method and the type of silica support employed (MCM-41, SBA-15, UVM-7 and Hollow Silica) on the efficacy of folic acid encapsulation, but also the influence of the morphology and porous system on the folic acid delivery profile from different supports. Folic acid release studies from different supports with various pH values have demonstrated that the designed systems are capable of smartly modulating the delivery of the folic acid dependent on the pH of the medium (inhibition of the release at an acidic pH -stomach-, controlled release at a neutral pH -intestine-).
This capacity makes these developed delivery systems an excellent alternative to direct fortification to successfully modulate the bioaccessibility of folic acid along the gastrointestinal tract. The stability of the supports during an in vitro digestive process was evaluated, and demonstrated that not only small particles can be attacked during the digestion process, but also the functionalization with organic molecules, which act as molecular gates, prevents this attack. Finally, the cell viability studies carried out with four different cell lines revealed that neither the supports nor their degradation products caused any specific toxicity during the in vitro digestive process.
The second part evaluates the influence of adding different silica supports to two food matrices: gelatin gels and yoghurts. This technological approach enabled us to know that the capacity of these smart systems to deliver folic acid in a controlled manner during an in vitro digestive process is mantained even after their incorporation in stirred yoghurt. The effect of the matrices on the gel's physical properties depends on the particle size, functionalization and concentration.
Finally, this thesis tested that the optimization of folic acid loading, achieved in the first part of the thesis, allowed the fortification of yoghurt with 100% of the recommended daily allowance of folic acid with a very low amount of the system. This fortification affected neither the physico-chemical properties of the yoghurt, nor bacterial viability.
In summary, it was concluded that the present thesis globally deals with folic acid encapsulation in silica porous matrices to be used in nutritional and food applications, which include the optimization of loading, release studies at diferent pH, in vitro digestions, stability studies of the employed matrixes, biocompatibility studies, and studies into the influence of their addition to food matrixes. The obtained results positively exhibit that the developed smart folic acid delivery systems open up a new way of fortifying food without endangering the properties of the food to which they are added. / [ES] La presente tesis doctoral que lleva por título "Encapsulación de ácido fólico en soportes porosos de óxido de silicio: una aproximación nutricional y tecnológica" está centrada en el desarrollo de nuevos sistemas inteligentes de liberación controlada de ácido fólico para aplicaciones nutricionales.
La primera parte de la tesis muestra la encapsulación de ácido fólico en matrices porosas de óxido de silicio funcionalizadas con poliaminas desde una aproximación nutricional. En ella se ha evaluado la influencia del método de cargado y del tipo de soporte de óxido de silicio utilizado (MCM-41, SBA-15, UVM-7 y Hollow Silica) en la eficacia de encapsulación de ácido fólico. En esta primera parte, también se ha evaluado la influencia de la morfología y el sistema de poros de los diferentes soportes en el perfil de liberación del ácido fólico desde los mismos. Los estudios de liberación de ácido fólico desde los diferentes soportes a diferentes valores de pH han demostrado que los sistemas diseñados son capaces de modular inteligentemente la liberación de ácido fólico en función del pH del medio (inhibición de la liberación a pH ácido -estómago-, liberación controlada a pH neutro -intestino-).
Esta capacidad convierte a los sistemas liberación desarrollados en una alternativa excelente a la fortificación directa para modular exitosamente la bioaccesibilidad del ácido fólico a lo largo del tracto gastrointestinal. Por otra parte, se ha evaluado la estabilidad de los soportes durante un proceso de digestión in vitro, demostrando que si bien algunos soportes pueden ser atacados durante la digestión, la funcionalización con moléculas que actúan como puertas moleculares previene este ataque. Por último, los estudios de viabilidad celular llevados a cabo en cuatro tipos de líneas celulares demuestran que ni los soportes, ni los productos de degradación de los mismos durante el proceso de digestión in vitro promueven ningún tipo de toxicidad inespecífica.
En la segunda parte se ha evaluado la influencia de la adición de diferentes soportes de óxido de silicio a dos matrices alimentarias, geles de gelatina y yogures. Esta aproximación tecnológica ha permitido conocer que la capacidad de estos sistemas inteligentes para liberar controladamente el ácido fólico a lo largo de un proceso de digestión in vitro se mantiene incluso tras su incorporación en yogures batidos. Por otra parte, se ha comprobado que el efecto de las matrices sobre las propiedades físicas de los geles, es dependiente tanto del tamaño de las partículas, como de su funcionalización y concentración. Por último, se ha comprobado que debido a la optimización del cargado de ácido fólico alcanzada en la primera parte de la tesis, se puede lograr una fortificación de un yogur con el 100% de la cantidad diaria recomendada de ácido fólico con una cantidad tan pequeña de sistema que ni las propiedades físico-químicas de un yogur, ni la viabilidad bacteriana se ven comprometidas.
En resumen, se puede concluir que la presente tesis ha abordado de una manera global la encapsulación de ácido fólico en matrices porosas de óxido de silicio para ser utilizados en aplicaciones nutricionales y alimentarias incluyendo estudios de optimización de cargado, estudios de liberación en función del pH, digestiones in vitro, estudios de estabilidad de las matrices utilizadas, estudios de biocompatibilidad, así como estudios de la influencia de la adición de estos sistemas inteligentes en matrices alimentarias. Los resultados obtenidos han puesto de manifiesto que los sistemas inteligentes de liberación de ácido fólico desarrollados abren la puerta a una nueva manera de fortificar los alimentos sin comprometer sus características. / [CA] La present tesi doctoral, que porta per títol "Encapsulació d'àcid fòlic en suports porosos d'òxid de silici: una aproximació nutricional i tecnològica" està centrada en el desenvolupament de nous sistemes intel·ligents de lliberació controlada d'àcid fòlic per a aplicacions nutricionals.
La primera part de la tesi mostra l'encapsulació d'àcid fòlic en matrius poroses d'òxid de silici funcionalitzades amb poliamines des d'una aproximació nutricional. En esta part, s'ha avaluat la influència del mètode de carrega i del tipus de suport d'òxid de silici que s'ha emprat (MCM-41, SBA-15, UVM-7 i Hollow Silica) en l'eficàcia de l'encapsulació d'àcid fòlic. En esta primera part, també s'ha avaluat la influència de la morfologia i el sistema de porus dels diferents suports en el perfil d'alliberament de l'àcid fòlic des dels mateixos. Els estudis d'alliberament d'àcid fòlic des dels diferents suports a diferents valors de pH han demostrat que els sistemes dissenyats són capaços de modular intel¿ligentment l'alliberament d'àcid fòlic en funció del pH del medi (inhibició de l'alliberament a pH àcid -estómac-, alliberament controlat a pH neutre -intestí-).
Esta capacitat fa dels sistemes desenvolupats una excel·lent alternativa a la fortificació directa per a modular amb èxit la bioaccessibilitat de l'àcid fòlic a través del tracte gastrointestinal. D'altra banda, s'ha avaluat l'estabilitat dels suports en un procés de digestió in vitro, demostrant que mentre que les partícules menudes poden ser atacades durant la digestió, la funcionalització amb molècules orgàniques que actuen com a portes moleculars prevé aquest atac. Per últim, els estudis de viabilitat cel·llular duts a terme en quatre tipus de línies cel·lulars demostren que ni els soports, ni els productes de degradació dels mateixos durant el procés de digestió in vitro promouen cap tipus de toxicitat inespecífica.
En la segona part, s'ha avaluat la influència de l'addició de diferents sopors d'òxid de silici a dos matrius alimentàries, gels de gelatina i iogurts. Esta aproximació tecnològica ha permés conéixer que la capacitat d'aquests sistemes intel·ligents per alliberar controladament àcid fòlic durant un procés de digestió in vitro es manté fins i tot després de ser incorporats en iogurts batuts. D'altra banda, s'ha comprovat que l'efecte de les matrius sobre les propietats físiques dels gels, és dependent tant de la grandària de les partícules, com de la seua funcionalització i concentració.
Per últim, s'ha comprovat que a causa de l'optimització del carregat d'acid fòlic alcançada en la primera part de la tesi, es pot aconseguir una fortificació d'un iogurt amb el 100% de la quantitat diària recomanada d'àcid fòlic amb una quantitat tan baixa del sistema que ni les propietats físico-químiques d'un iogurt, ni la viabilitat bacteriana se'n veuen compromeses.
En resum, es pot concluir que en la present tesi s'ha abordat d'una manera global l'encapsulació d'àcid fòlic en matrius poroses d'òxid de silici per a ser utilitzades en aplicacions nutricionals i alimentàries, que inclouen estudis d'optimització de carregat, estudis d'alliberament en funció del pH, digestions in vitro, estudis d'estabilitat de les matrius utilitzades, estudis de biocompatibilitat, així com estudis de la influència de l'addició d'aquests sistemes en matrius alimentàries. Els resultats obtesos han posat de manifest de forma positiva que els sistemes intel·ligents d'àcid fòlic que s'han desenvolupat obrin una porta a una nova manera de fortificar els aliments sense comprometre les seues caracterísitiques. / Pérez Esteve, E. (2015). ENCAPSULATION OF FOLIC ACID IN MESOPOROUS SILICA SUPPORTS: A NUTRITIONAL AND TECHNOLOGICAL APPROACH [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/58613 / TESIS / Premios Extraordinarios de tesis doctorales / Compendio
|
192 |
Adipogenesis using human adipose tissue-derived stem cells sustaining release of basic fibroblast growth factor / 脂肪由来幹細胞、徐放性線維芽細胞増殖因子を用いた脂肪形成Ito, Ran 24 March 2014 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第18133号 / 医博第3853号 / 新制||医||1001(附属図書館) / 30991 / 京都大学大学院医学研究科医学専攻 / (主査)教授 坂田 隆造, 教授 瀬原 淳子, 教授 開 祐司 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DGAM
|
193 |
DESIGN AND CHARACTERIZATION OF GELATIN HYDROGELS INCORPORATING LOW-MOLECULAR-WEIGHT DRUGS FOR TISSUE REGENERATION / 組織再生のための低分子薬物含有ゼラチンハイドロゲルの創製と評価Saito, Takashi 23 March 2015 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(工学) / 甲第19010号 / 工博第4052号 / 新制||工||1623(附属図書館) / 31961 / 京都大学大学院工学研究科高分子化学専攻 / (主査)教授 田畑 泰彦, 教授 岩田 博夫, 教授 木村 俊作 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DFAM
|
194 |
Studies on Hybrid Porous Coordination Polymers with Functional Inorganic Materials / 多孔性配位高分子と機能性無機化合物の複合化に関する研究Nakahama, Masashi 25 May 2015 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(工学) / 甲第19189号 / 工博第4066号 / 新制||工||1627(附属図書館) / 32181 / 京都大学大学院工学研究科合成・生物化学専攻 / (主査)教授 北川 進, 教授 濵地 格, 教授 森 泰生 / 学位規則第4条第1項該当 / Doctor of Philosophy (Engineering) / Kyoto University / DGAM
|
195 |
Characterization of polymorphic forms and in vitro release of etoposide from poly-DL-lactic and poly-DL-lactic-co-glycolic acid micromatricesJasti, Bhaskara Rao 01 January 1995 (has links) (PDF)
Etoposide has been shown to be effective in the treatment of testicular and small-cell lung cancers, lymphoma, leukemia and Kaposi's sarcoma. Several clinical investigations have suggested that the prolonged maintenance of greater than 1 $\mu$g/ml concentration in plasma would provide better therapeutic response in patients. Thus use of a sustained/controlled release formulation of etoposide was indicated. This investigation focused on the potential for the development of a sustained/controlled release dosage form of etoposide for a 7-15 day delivery using selected polylactic and polylactic-co-glycolic acid polymers. During the course of studies involving the enhancement of aqueous solubility of etoposide in our laboratory evidence of a potential thermally induced polymorphic transition was detected. Therefore, further characterization of this phenomenon was also included in this investigation. Thermal behavior of etoposide was characterized by differential scanning calorimetry, thermal gravimetric analysis, X-ray diffractometry, mass spectroscopy, IR spectra and HPLC analyses. A method for the preparation of micromatrices of etoposide was developed utilizing a suspension and solvent evaporation technique. DSC, IR and NMR investigations did not indicate any potential etoposide-polymer interaction. Etoposide I, a monohydrate, underwent a dehydration reaction between 85-115$\sp\circ$C to yield Etoposide Ia, which upon further heating melted at 198$\sp\circ$C and crystallized to a new polymorph, Etoposide IIa at 206$\sp\circ$C. Etoposide IIa was found to melt at 269$\sp\circ$C and converted to its hydrated form, Etoposide II when exposed to atmosphere at room temperature. The polymorphic transition was found to be irreversible and monotropic. Etoposide I, the currently marketed drug was used in all delivery systems examined. Formulation studies with polylactic acid polymers indicated that the molecular weight of the polymer was a key parameter in influencing the percent of drug entrapped in the micromatrices, particles size distribution and the drug release profiles. Glycolide-containing polymers demonstrated control of etoposide release only at low drug loadings: larger micromatrices showing better control. Polylactic acid 50,000 at 1:5 and 1:15 drug to polymer ratios exhibited maximum rate of drug release of 1.57 mg/hr. At this release rate, a delivery system containing 350 mg of etoposide could be expected to maintain a plasma concentration of 1.08 $\mu$g/ml over a period of 7 days. Additionally, drug release profile of polylactide-co-glycolide (85:15, 75-180 $\mu$m) microsphere formulation with 1:10 drug to polymer ratio, was found to be more appropriate for a 15-day release system based upon 700 mg of etoposide.
|
196 |
’Smart’, Injectable, Magnetic Nanocomposite Hydrogels for Biomedical Applications with a Focus on Externally-Mediated Release / ‘Smart’ Magnetic Nanocomposite Hydrogels for Drug DeliveryCampbell, Scott Brice January 2017 (has links)
The capability of precisely controlling the kinetics of therapeutic delivery at the optimal location and rate for a given patient would have great potential to improve health and well-being in a range of current drug therapies (insulin, chemotherapeutics, vaccines, etc.). Indeed, if successfully developed, locally administered injectable drug delivery vehicles capable of remotely-triggered release would be the gold standard for many treatments.
Multiple injectable nanocomposites have been investigated for this purpose that are generally comprised of a thermosensitive polymeric material and superparamagnetic iron oxide nanoparticles (SPIONs). SPIONs generate heat when exposed remote alternating magnetic fields (AMFs), and the transfer of this heat to thermosensitive polymers can be used to control the release of therapeutics. Ideally, these systems would be capable of returning to their original state and basal release rate when the external AMF trigger is removed.
Several novel injectable nanocomposite materials that explore interactions between SPIONs and thermosensitive polymers to mediate drug release, from the macroscale to the nanoscale, were developed and demonstrated to be capable of remotely-triggered, AMF-mediated enhanced release. The macroscale magnetic nanocomposites have thermosensitive hydrogel and/or microgel components that regulate release based on the heat produced from SPIONs in response to an external AMF. On the millimeter-scale, a microinjection system capable of producing thermosensitive hydrogel beads that could potentially incorporate SPIONs is described. On the nanoscale, nanoparticles with a glass transition temperature and thermosensitive microgels are combined with SPIONs and investigated for their remote, AMF-mediated release characteristics. The engineered macroscale and nanoscale systems are capable of up to ~4:1 and ~7:1 enhancements in release due to an AMF application, respectively, compared to the basal release rate.
Collectively, these nanocomposites represent a promising stride towards improved remote-actuation of drug release and a stepping stone for future attempts at precisely controlling the site and kinetics of drug release. / Thesis / Doctor of Philosophy (PhD) / This thesis focuses on the development of nanocomposite materials that can be injected into a specific location in the body and deliver therapeutic drugs by a remote-controlled process. These nanocomposites are composed of magnetic particles and polymers that respond to changes in temperature. The combination of these materials results in nanocomposites that can change their properties in response to specific magnetic fields to switch from releasing drug slowly (or not at all) to releasing drug quickly on demand. The changes are fully reversible and solely depend on whether the external magnetic field is switched on or off. These novel systems offer an alternative to therapies that require frequent injections, such as insulin for diabetes, or therapies that need the drug to be released in very precise locations, such as cancer treatments, and could improve the safety, reduce the risk of side effects, and lower the cost of many medical treatments.
|
197 |
Impact of material attributes & process parameters on critical quality attributes of the amorphous solid dispersion products obtained using hot melt extrusionSabnis, Aniket D. January 2019 (has links)
The feasibility of hot melt extrusion (HME) was explored for development of amorphous solid dispersion systems. Controlled release formulations were developed using a cellulose based derivative, AffinisolTMHPMC 100cP and 4M grades. BCS class II drugs ibuprofen and posaconazole were selected due to their difference in glass transition temperature and lipophilicity.
This study focused on investigation of the impact the material attributes and process parameters on the critical quality attributes in preparation of amorphous solid dispersions using hot melt extrusion. The critical quality attributes were sub divided into three main attributes of material, process and product.
Rheology of ibuprofen-Affinisol 100cP from melt phase to extrudate phase was tracked. A partial factorial design was carried out to investigate the critical parameters affecting HME. For optimisation of 40%IBU-Affinisol 100cP blends, a feed rate of 0.6kg/hr, screw speed of 500rpm and screw configuration with two mixing elements were found to be optimum for single phase extrudates. ATR-FTIR spectroscopy was found to be an indirect technique of choice in predicting the maximum ibuprofen drug load within extrudates. Prediction was based on the prepared extrudates without charging them to stability conditions.
An alternative strategy of incorporation of di-carboxylic acids to increase the dissolution of posaconazole-Affinisol 4M blends was investigated. Succinic acid and L- malic acid incorporation was found to increase the dissolution of posaconazole. Although, the extrudates crystallised out quicker than the naïve posaconazole-Affinisol 4M, but free posaconazole formed eutectic and co-crystal with succinic and L-malic acid within extrudates. This lead to an increase in dissolution of the extrudates compared to day 0.
|
198 |
Preparation, Characterization, and <i>In Vitro</i> Protein Release Studies in Pharmaceutically relevant Lecithin MicroemulsionsParekh, Khushboo K. 25 May 2011 (has links)
No description available.
|
199 |
Use of Silicone Adhesive for Improving Oral Controlled DeliveryTolia, Gaurav 28 August 2018 (has links)
No description available.
|
200 |
Novel Remediation Schemes for Groundwater and Urban RunoffOlson, Pamela Renee 26 July 2011 (has links)
No description available.
|
Page generated in 0.0655 seconds